Neomi Moay

Title: Neomi Moay: Innovator in Monoclonal Antibodies

Introduction

Neomi Moay is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on therapeutic and diagnostic applications, showcasing his commitment to advancing medical science.

Latest Patents

Neomi Moay holds a patent for a novel invention titled "Complement-dependent cytolytic anti-Trichomonas vaginalis monoclonal." This patent involves the development of monoclonal antibodies that are specific to Trichomonas vaginalis. These antibodies possess complement-fixing abilities and can lyse Trichomonas vaginalis in the presence of complement. This innovation has potential applications in the therapy and diagnosis of trichomoniasis. The patent also discloses hybridomas producing these antibodies and compositions comprising them.

Career Highlights

Neomi Moay is associated with Interpharm Laboratories Ltd., where he continues to work on groundbreaking research and development projects. His expertise in monoclonal antibodies has positioned him as a key figure in the biotechnology sector.

Collaborations

Neomi collaborates with Enrica Draghi, who is also involved in the research and development of innovative solutions in the field. Their partnership exemplifies the collaborative spirit that drives advancements in biotechnology.

Conclusion

Neomi Moay's contributions to the field of monoclonal antibodies highlight his innovative spirit and dedication to improving healthcare. His work not only addresses critical medical challenges but also paves the way for future advancements in the treatment and diagnosis of diseases.